Trish L.
She didn't want to be patient with herself. She wanted a protocol that worked with her life — wine events, donor dinners, postmenopause, and all.
44 lbs lost over 12 months. BHRT initiated alongside the GLP-1. Bone density preserved. Sleep restored. Off alprazolam. And a version of herself she recognizes again — on her own timeline, not the divorce narrative's.
She Was Done Being the Divorce Story
Trish is a 55-year-old Director of Development at a regional health-focused nonprofit — major-gift fundraiser, three to four evening events weekly during gala season, restaurants five nights a week. She has been building other people's capacity for decades. After 27 years of marriage, her husband initiated the divorce. In the 18 months since it finalized, she gained another 8 lbs on top of the 40 she had gained in the final decade of the marriage. She moved into a smaller condo. She bought clothes in sizes she resented. She tried a magazine "divorce rebuild" plan for 11 days. She saw a therapist who told her to be patient with herself.
Trish does not want to be patient. She wants a protocol. She is postmenopausal — last period 18 months ago, never started HRT despite the textbook candidacy — and she has been running on disrupted sleep, elevated cortisol, and wine-driven evenings that come with the job. She knows she will eventually want to date again. She is not there yet. But she refuses to arrive at that chapter as the version of herself she sees in the mirror right now.
She came to FLOA with a specific ask: manage both the weight and the hormones under one roof, build a protocol that works within her fundraising-event lifestyle rather than against it, and don't tell her to give up the wine entirely — because that is not realistic and she has been lied to by programs that pretend otherwise.
What Postmenopause + Divorce + Fundraising Looks Like
- 48 lbs total gained — 40 over the last decade of marriage, 8 in the 18 months since divorce
- Postmenopausal: estradiol 9 pg/mL, FSH 78 — had never started HRT despite textbook candidacy
- Significant insulin resistance: HOMA-IR 3.8, fasting insulin 17 mIU/L
- A1c 5.7% — entering prediabetic range; fasting glucose 96
- Testosterone 12 ng/dL — low-normal postmenopausal; DHEA-S age-appropriately low
- hs-CRP 3.2 mg/L — elevated systemic inflammation; ALT 34 borderline
- Vitamin D 22 ng/mL — insufficient; bone density baseline not yet established
- Sleep severely disrupted since the divorce — cortisol-driven; alprazolam used 1–2 nights/week
- Wine intake 8–10 drinks weekly — driven by fundraising culture and post-divorce stress, not preference
- Restaurants 5 nights/week — no practical meal architecture for her social calendar
- No consistent exercise in over a decade — bone density a real and unaddressed clinical risk
- Social and dating life to rebuild on her own timeline — identity in active reconstruction
Dual-Track — Metabolic and Hormonal, Both Under One Roof
Full postmenopausal hormone panel: estradiol, FSH, total and free testosterone, DHEA-S, progesterone. BHRT candidacy confirmed — no breast cancer history, no clotting history, low cardiovascular risk. DEXA scan for bone density baseline established before any weight loss — clinically essential for a postmenopausal female initiating aggressive fat loss. Metabolic panel: fasting insulin, HOMA-IR, A1c, full lipid panel, hs-CRP, ALT, vitamin D, B12, ferritin. Alprazolam use documented and flagged for supervised taper.
Tirzepatide started at 2.5mg weekly, titrated to 5mg at week 6, and held there throughout the entire 12-month program — no escalation needed. The dual GIP/GLP-1 mechanism was particularly suited to her insulin resistance profile and postmenopausal metabolic environment. Critically, tirzepatide quieted the wine-driven evening eating that had defined her post-divorce period — not by eliminating the wine, but by removing the hunger cascade that the wine had been triggering.
Transdermal estradiol 0.05mg patch twice weekly, oral micronized progesterone 100mg nightly, low-dose testosterone cypionate 0.05mL weekly — all initiated at month 1, managed by FLOA's medical team. The simultaneous initiation was intentional: estradiol and progesterone directly support fat distribution, insulin sensitivity, and sleep architecture in postmenopausal women. Initiating BHRT after weight loss begins, rather than alongside it, leaves those mechanisms unaddressed for months. Bone density rescan planned at month 12.
Added from month 1. At 55, postmenopausal, losing weight — sarcopenia and bone density loss are not theoretical risks; they are active competing outcomes that the protocol had to defend against. CJC-1295/Ipamorelin supports GH-axis function, lean mass preservation, and sleep architecture restoration. Combined with oral micronized progesterone's GABAergic sleep benefit, sleep was noticeably improved within two weeks of initiation — well before alprazolam tapering began.
AOD-9604 added at month 2 for visceral fat mobilization — the fat depot most concentrated by cortisol-driven post-divorce stress gain and postmenopausal estrogen loss. The Metabolic Two-Piece: tirzepatide managing appetite and insulin dynamics from the demand side; AOD-9604 mobilizing visceral adipose tissue from the supply side.
Protein First targeting 110g/day. Donor-dinner ordering protocol: always lead with protein and vegetables, share dessert rather than decline it, pre-eat before events to avoid arriving starving. Alcohol reduced from 8–10 to 3–4 drinks weekly — not eliminated. Strength training twice weekly as a bone density mandate, not optional. 7,000 daily steps. No formal fasting protocol until month 5 — cortisol-driven sleep disruption and BHRT initiation made early fasting counterproductive.
Phase by Phase
Sleep Restored in 2 Weeks — BHRT + GLP-1 Simultaneously Active
Tirzepatide, BHRT, and CJC-1295/Ipamorelin all initiated. Down 8 lbs. Sleep noticeably improved within 2 weeks — the combined effect of progesterone's GABAergic activity and CJC/Ipamorelin's sleep architecture support. Wine-driven evening eating began quieting as tirzepatide removed the hunger cascade beneath it. Pre-event eating protocol installed for the fundraising calendar.
→ Down 8 lbs; sleep improving week 2; BHRT active; GLP-1 active
AOD-9604 Added — Energy Markedly Improved on BHRT
Titrated to 5mg tirzepatide. AOD-9604 added for visceral fat mobilization. Down 15 lbs total. BHRT producing meaningful energy improvement — estradiol, progesterone, and low-dose testosterone combining to restore what postmenopause had taken. Strength training established twice weekly without resistance from the physical exhaustion that had made it feel impossible for years.
→ Down 15 lbs; AOD-9604 active; energy improving markedly on BHRT
Wine Stable at 3–4 Drinks — Alprazolam Reducing
Held at 5mg. Down 22 lbs. Wine intake stabilized organically at 3–4 drinks weekly — down from 8–10, without a formal elimination mandate. Alprazolam down to once weekly as sleep architecture improved on BHRT and peptide support. Donor dinners navigated successfully on the ordering protocol — no event had derailed the program. Waist reduction visibly noticeable in clothing fit.
→ Down 22 lbs; wine 3–4/week; alprazolam once weekly; wardrobe shifting
Hormone Panel Confirms Optimization — A1c Out of Prediabetic Range
Held at 5mg. Down 30 lbs. Hormone panel: estradiol in therapeutic range, testosterone within target female range on supplementation. A1c 5.4% — out of prediabetic range. Gentle 14:10 eating window introduced now that sleep was stable and BHRT was established. The alprazolam that had been a nightly presence during the divorce was now used roughly monthly.
→ Down 30 lbs; A1c 5.4%; hormones optimized; fasting window introduced
38 lbs Down — First 24-Hour Fast — Two Sizes Smaller
Down 38 lbs. First 24-hour fasts implemented — twice monthly. Back in a wardrobe two full sizes smaller than her divorce-gain size. BHRT continued without adjustment. Strength training twice weekly as a fixed identity, not a chore. The cortisol-driven sleep disruption that had started the night her husband told her he was leaving had been replaced by consistent, restorative sleep.
→ Down 38 lbs; wardrobe two sizes smaller; 24-hour fasts; sleep restored
44 lbs Lost — Bone Density Preserved — Herself Again
205 → 161 lbs. DEXA at month 12: bone density preserved — the most important non-weight clinical outcome for a postmenopausal female on an aggressive weight loss trajectory. Tirzepatide reduced to 2.5mg every 10 days — beginning the taper toward GLP-1 independence while BHRT continues indefinitely. Alprazolam now used roughly once monthly. Trish described herself, for the first time in three years, as recognizable.
→ 44 lbs lost; bone density preserved; BHRT stable; tirzepatide tapering
"Postmenopausal weight loss without BHRT is a harder problem than it needs to be. Estrogen loss directly drives visceral fat redistribution, insulin resistance, and bone density decline — and those mechanisms are still active while the diet and GLP-1 are working. Initiating BHRT at month 1, not after the weight loss stabilizes, means the hormonal environment is supporting the fat loss rather than fighting it. That's not a cosmetic choice. It's a metabolic one."
What Changed at 12 Months
Weight & Body Composition
44 lbs lost (205 → 161). 36 lbs fat lost, 8 lbs lean mass preserved per InBody — strong lean mass retention for a postmenopausal female on aggressive weight loss. Waist down 7 inches.
Bone Density Preserved
DEXA at month 12 confirmed bone density preserved — the most clinically important non-weight outcome at 55. BHRT, strength training, and CJC-1295/Ipamorelin working together to defend against the bone loss that aggressive postmenopausal weight loss risks.
Hormonal Restoration
Estradiol from 9 → therapeutic range on BHRT. Total T from 12 → 38 ng/dL within target female range. Vitamin D from 22 → 51 ng/mL. The full postmenopausal hormonal picture addressed — not just the weight.
Metabolic Reversal
HOMA-IR from 3.8 → 1.4. Fasting insulin from 17 → 7 mIU/L. A1c from 5.7 → 5.4% — out of prediabetic range. hs-CRP from 3.2 → 0.9. ALT from 34 → 22. Prediabetes trajectory reversed.
Sleep Restored
Divorce-driven sleep disruption resolved through progesterone and CJC-1295/Ipamorelin. Alprazolam reduced from 1–2 nights/week to roughly once monthly — a managed taper, not abrupt discontinuation.
Lifestyle Compatible
Fundraising-event calendar navigated successfully throughout — no program abandonment. Wine reduced from 8–10 → 3–4 drinks weekly without an abstinence mandate. Donor dinners managed on protocol without social friction.
| Category | What Changed |
|---|---|
| Bone Density | Preserved on DEXA at month 12 — the highest-stakes clinical outcome for her age and trajectory |
| Sleep | Divorce-disrupted → consistently restorative; restored within 2 weeks of BHRT + peptide initiation |
| Alprazolam | 1–2 nights/week → roughly monthly; reduced as sleep architecture normalized under BHRT |
| Wine | 8–10 drinks/week → 3–4; reduced organically as tirzepatide quieted the hunger cascade beneath it |
| Wardrobe | Out of resentful divorce sizes; two full sizes smaller by month 8 |
| Fundraising Calendar | 3–4 donor events weekly navigated on protocol throughout — zero event-driven derailments |
| Strength Training | Zero exercise for 10+ years → twice-weekly strength sessions as a bone density mandate by month 2 |
| Prediabetes | A1c 5.7 → 5.4%; HOMA-IR 3.8 → 1.4 — prediabetic trajectory reversed |
| BHRT | 18 months postmenopausal without HRT → fully optimized hormonal environment by month 3 |
| Identity | Recognized herself in the mirror again — on her own timeline, not the divorce narrative's |
"Every program I'd tried told me to give things up. Give up the wine. Give up the dinners. Give up the lifestyle that comes with my job. FLOA actually looked at my life and built something that worked inside it. I still go to donor dinners three nights a week. I still have wine — just less of it. I lost 44 pounds, my bone density is intact, I sleep without medication most nights, and I'm in clothes I actually want to wear. I didn't get back the woman I was at 35. I got a better version of the woman I am at 55. That's more than I came in asking for."
Clinical Takeaways
Trish's case illustrates why postmenopausal weight loss is a different clinical problem from weight loss at 35 — and why managing it with a GLP-1 alone misses critical biology. Estrogen loss directly drives visceral fat redistribution, insulin resistance, and accelerated bone density decline. These mechanisms don't pause while a diet works. Initiating BHRT simultaneously with the GLP-1 — rather than deferring it until after the weight loss stabilized — meant the hormonal environment was actively supporting fat loss rather than working against it. The simultaneous approach also addressed the sleep disruption immediately, which mattered enormously for cortisol regulation, metabolic function, and patient adherence.
Bone density deserves specific attention. Aggressive weight loss in a postmenopausal female is not a neutral event for skeletal health — rapid fat loss without lean mass preservation and hormonal support can accelerate the bone density loss that estrogen withdrawal had already begun. The DEXA at baseline was not optional; it established the clinical baseline against which the month 12 scan confirmed that bone density had been protected. BHRT, twice-weekly strength training, and CJC-1295/Ipamorelin were all working together on that outcome from month one.
The lifestyle compatibility point also matters clinically. Trish works in fundraising. Her professional life is organized around social eating and drinking. A protocol that requires abstinence from that environment is not a protocol she can maintain — and a protocol she can't maintain produces no long-term outcome. Building the donor-dinner ordering structure, the pre-event eating approach, and the alcohol reduction without elimination created the conditions for 12 months of consistent adherence in a genuinely challenging social environment. The weight loss happened because the protocol fit her life, not because she briefly fit a protocol.
Postmenopause Isn't the End of the Story — It's a New Set of Levers
If you're postmenopausal, struggling with weight that wasn't there before, and no one has talked to you about BHRT alongside the metabolic work — you're not getting the full picture. Estrogen loss is a metabolic event. Treating it as one changes the outcome.
Individual results vary. This case study is for educational purposes only. © Dr. Jones DC — FLOA Protocol.